KIILANI BUCZKOWSKI: Open Payments
NPI 1265861041 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 23 payments from 12 companies in 2025. Trend: 2023 $660 · 2024 $643 · 2025 $541
Food & beverage: $469Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $149 |
| UCB, Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $50 |
| Almirall LLC | 2 | $43 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| LEO Pharma Inc. | 1 | $27 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $27 |
| Fidia Pharma USA Inc. | 1 | $26 |
Products named: TREMFYA, Bimzelx, LIBTAYO, JUBLIA, TALTZ, BOTOX, ADBRY, Seysara.
Industry payments across AZ — which companies pay providers there.
